Drugs Regulator
- All
- News
- Videos
-
8 Tips To Increase GLP-1 Hormone Levels Naturally
Glucagon-like peptide-1 (GLP-1) is a hormone secreted after eating to stimulate insulin release and suppress glucagon, a hormone that raises blood sugar, helping to lower blood sugar.
-
Central Drugs Body Revamps Testing Permissions To Fast-Track Drug Approvals in India
India's drug regulator Central Drugs Standard Control Organization has revised testing permission norms to speed up approvals. From June 1, 2026, companies can start lab testing immediately after application, a step aimed at reducing delays while mai
-
New Study Links Popular Diabetes Drugs To Reduced Risk Of Strokes
GLP-1RA drugs may lower risk of deadly subarachnoid haemorrhage strokes in diabetes patients.
-
Chemists' Association Writes To PM Modi Over Concerns Of AI-Generated Fake Prescriptions
In a letter, the chemists' body flagged the growing trend of AI-generated prescriptions, often carrying fictitious hospital names and fabricated patient details, being accepted by certain online platforms.
-
Mexican Drug Cartel Drones Trigger Laser Strike That Shut Down US Airspace
The government's ability to deal with drones that pose a threat on American soil has been questioned this week after the use of a laser designed to shoot down drones near the border in Texas led to the abrupt closure of the airspace over El Paso
-
Cancer Drug Imfinzi Gets Indian Regulator's Approval For Use In First-Line Treatment
AstraZeneca Pharma India Limited on Tuesday said it has received permission from the Central Drugs Standard Control Organisation to sell and distribute Durvalumab solution for infusion used in cancer treatment.
-
Union Budget 2026 Signals Prevention-Led, Innovation-Driven Healthcare Shift, Say Industry Leaders
Union Budget 2026 places strong emphasis on prevention, biopharma innovation and mental health, with industry leaders highlighting the importance of early screening, stronger regulation and faster access to global medical innovation.
-
Historic India-EU Trade Deal Could Impact Prices Of Weight Loss And Lifesaving Drugs, Here's How
India's landmark free trade deal with the European Union may lower import costs for some medicines, including weight-loss and lifesaving drugs. But experts say patient prices will depend on patents, regulation, and how benefits pass through the suppl
-
Indian Drugmakers Recall Medicines In The US Over Manufacturing Issues
Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Drug Administration (USFDA).
-
Indian Drug Regulators Flag 167 Medicines As Unsafe In December 2025
The Central Drugs Standard Control Organisation (CDSCO) on Wednesday declared 167 drug samples tested by the Central and state drugs regulatory authorities as not of standard quality (NSQ)' in its monthly drug alert for Dece
-
8 Tips To Increase GLP-1 Hormone Levels Naturally
Glucagon-like peptide-1 (GLP-1) is a hormone secreted after eating to stimulate insulin release and suppress glucagon, a hormone that raises blood sugar, helping to lower blood sugar.
-
Central Drugs Body Revamps Testing Permissions To Fast-Track Drug Approvals in India
India's drug regulator Central Drugs Standard Control Organization has revised testing permission norms to speed up approvals. From June 1, 2026, companies can start lab testing immediately after application, a step aimed at reducing delays while mai
-
New Study Links Popular Diabetes Drugs To Reduced Risk Of Strokes
GLP-1RA drugs may lower risk of deadly subarachnoid haemorrhage strokes in diabetes patients.
-
Chemists' Association Writes To PM Modi Over Concerns Of AI-Generated Fake Prescriptions
In a letter, the chemists' body flagged the growing trend of AI-generated prescriptions, often carrying fictitious hospital names and fabricated patient details, being accepted by certain online platforms.
-
Mexican Drug Cartel Drones Trigger Laser Strike That Shut Down US Airspace
The government's ability to deal with drones that pose a threat on American soil has been questioned this week after the use of a laser designed to shoot down drones near the border in Texas led to the abrupt closure of the airspace over El Paso
-
Cancer Drug Imfinzi Gets Indian Regulator's Approval For Use In First-Line Treatment
AstraZeneca Pharma India Limited on Tuesday said it has received permission from the Central Drugs Standard Control Organisation to sell and distribute Durvalumab solution for infusion used in cancer treatment.
-
Union Budget 2026 Signals Prevention-Led, Innovation-Driven Healthcare Shift, Say Industry Leaders
Union Budget 2026 places strong emphasis on prevention, biopharma innovation and mental health, with industry leaders highlighting the importance of early screening, stronger regulation and faster access to global medical innovation.
-
Historic India-EU Trade Deal Could Impact Prices Of Weight Loss And Lifesaving Drugs, Here's How
India's landmark free trade deal with the European Union may lower import costs for some medicines, including weight-loss and lifesaving drugs. But experts say patient prices will depend on patents, regulation, and how benefits pass through the suppl
-
Indian Drugmakers Recall Medicines In The US Over Manufacturing Issues
Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Drug Administration (USFDA).
-
Indian Drug Regulators Flag 167 Medicines As Unsafe In December 2025
The Central Drugs Standard Control Organisation (CDSCO) on Wednesday declared 167 drug samples tested by the Central and state drugs regulatory authorities as not of standard quality (NSQ)' in its monthly drug alert for Dece
